MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

General Obstetrics and Gynecology: Clinical Research

CMO-US-WH-0444: Prospective, Non-Interventional/ Observational Registry of US Uterine Fibroids Patients (Capture-US)

Collection of Bio-fluid Samples from Pregnant Women for the Evaluation of Biomarkers for Preeclampsia Protocol: DLS Pregnant Women 2014

LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered with Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids
Keywords: Contraception, Menopause, Fibroids, Abnormal bleeding, Libido

M360-L105 - A Phase 3, Multi-center, Open-label Study of a Levonorgestrel 52mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
Keywords: Menstrual Bleeding,

MIT-Es0001-C302: A Multicenter, Open-label, Single-Arm Study to Evaluate the Contraceptive Efficacy and Safety of a Combined Oral Contraceptive Containing 15 mg Estetrol and 3 mg Drospirenone

MVT-601-3001: LIBERTY 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co-Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

Protocol: AMP002 - A Single-Arm, Phase III, Open-Label, Multicenter, Study in Women aged 18-35 Years of the Contraceptive Efficacy and Safety of Amphora® Contraceptive Vaginal Gel

Protocol: DLS PAP 2016 The Collection of Swabs from Women During a Vaginal or Cervical Examination for Research and Development Purposes

Protocol: ERC-242 Prasterone (DHEA) for the treatment of Hypoactive Sexual Desire Disorder (Placebo Controlled, Double Blind and Randomized Phase III Study of Intravaginal prasterone)

1